Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CM512 Extension Study in Chronic Rhinosinusitis With Nasal Polyposis
NCT07519577Phase 2Not yet recruiting
- Sponsor
- Keymed Biosciences
- Start
- May 2026
- Primary completion
- May 2028
- Modality
- Bispecific Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of CM512 in chronic rhinosinusitis with nasal polyposis (CRSwNP), sponsored by Keymed Biosciences. Planned start May 2026; status: not yet recruiting.
02
Drugs
CM512
03
Conditions
chronic rhinosinusitis with nasal polyposis (CRSwNP)
Beyond the preview
Go deeper on NCT07519577.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07519577.